Elisa Birnbaum
Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 37 | 2023 | 159 | 2.580 |
Why?
| | Adenocarcinoma | 26 | 2023 | 927 | 0.900 |
Why?
| | Digestive System Surgical Procedures | 7 | 2020 | 111 | 0.890 |
Why?
| | Rectum | 8 | 2018 | 180 | 0.880 |
Why?
| | Colorectal Surgery | 6 | 2022 | 31 | 0.870 |
Why?
| | Laparoscopy | 16 | 2019 | 474 | 0.750 |
Why?
| | Fecal Incontinence | 11 | 2020 | 90 | 0.730 |
Why?
| | Neoadjuvant Therapy | 12 | 2023 | 474 | 0.610 |
Why?
| | Colectomy | 14 | 2022 | 107 | 0.580 |
Why?
| | Surgical Wound | 1 | 2018 | 27 | 0.550 |
Why?
| | Colon | 3 | 2019 | 304 | 0.520 |
Why?
| | Surgical Wound Infection | 2 | 2018 | 331 | 0.470 |
Why?
| | Anal Canal | 11 | 2014 | 101 | 0.470 |
Why?
| | Pelvic Floor Disorders | 3 | 2020 | 16 | 0.460 |
Why?
| | Rectal Prolapse | 5 | 2020 | 25 | 0.430 |
Why?
| | Neoplasm Recurrence, Local | 18 | 2019 | 1156 | 0.400 |
Why?
| | Neoplasm Staging | 25 | 2023 | 1486 | 0.370 |
Why?
| | Anus Neoplasms | 7 | 2009 | 33 | 0.360 |
Why?
| | Proctocolectomy, Restorative | 5 | 2016 | 22 | 0.350 |
Why?
| | Rectal Diseases | 3 | 2006 | 24 | 0.310 |
Why?
| | Rectal Fistula | 5 | 2013 | 26 | 0.300 |
Why?
| | Colonic Neoplasms | 7 | 2013 | 257 | 0.270 |
Why?
| | Postoperative Complications | 18 | 2022 | 2962 | 0.260 |
Why?
| | Colonic Diseases | 2 | 2006 | 36 | 0.260 |
Why?
| | Middle Aged | 62 | 2022 | 36359 | 0.250 |
Why?
| | Patient Reported Outcome Measures | 3 | 2020 | 502 | 0.250 |
Why?
| | Training Support | 1 | 2007 | 35 | 0.250 |
Why?
| | Treatment Outcome | 37 | 2023 | 11744 | 0.250 |
Why?
| | Aged | 49 | 2020 | 26251 | 0.230 |
Why?
| | Certification | 1 | 2007 | 117 | 0.220 |
Why?
| | Pelvic Floor | 3 | 2020 | 32 | 0.220 |
Why?
| | Perineum | 4 | 2008 | 36 | 0.210 |
Why?
| | Fistula | 3 | 2013 | 45 | 0.210 |
Why?
| | Fluorouracil | 8 | 2014 | 231 | 0.210 |
Why?
| | Male | 69 | 2022 | 73014 | 0.210 |
Why?
| | Colitis, Ulcerative | 4 | 2016 | 142 | 0.210 |
Why?
| | Female | 71 | 2022 | 79080 | 0.200 |
Why?
| | Aged, 80 and over | 34 | 2020 | 8351 | 0.200 |
Why?
| | Preoperative Care | 7 | 2014 | 375 | 0.190 |
Why?
| | Retrospective Studies | 35 | 2023 | 17291 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2007 | 353 | 0.180 |
Why?
| | Manometry | 8 | 2006 | 96 | 0.180 |
Why?
| | Societies, Medical | 3 | 2020 | 901 | 0.180 |
Why?
| | Humans | 84 | 2023 | 145625 | 0.180 |
Why?
| | Colonic Pouches | 2 | 2013 | 14 | 0.180 |
Why?
| | Prospective Studies | 17 | 2018 | 8087 | 0.180 |
Why?
| | Brachytherapy | 2 | 2001 | 132 | 0.170 |
Why?
| | Radiotherapy, Adjuvant | 11 | 2019 | 222 | 0.170 |
Why?
| | Pelvic Organ Prolapse | 2 | 2020 | 62 | 0.170 |
Why?
| | Radiation Injuries | 4 | 2009 | 149 | 0.160 |
Why?
| | Adult | 51 | 2020 | 40821 | 0.160 |
Why?
| | Disease-Free Survival | 14 | 2019 | 777 | 0.160 |
Why?
| | Follow-Up Studies | 19 | 2019 | 5397 | 0.160 |
Why?
| | Carcinoma, Squamous Cell | 6 | 2009 | 627 | 0.160 |
Why?
| | Combined Modality Therapy | 13 | 2016 | 1269 | 0.160 |
Why?
| | Constipation | 2 | 2020 | 98 | 0.150 |
Why?
| | Pneumoperitoneum | 1 | 2019 | 12 | 0.150 |
Why?
| | Radiotherapy Dosage | 9 | 2009 | 289 | 0.140 |
Why?
| | Urology | 1 | 2020 | 60 | 0.140 |
Why?
| | Skiing | 1 | 2019 | 50 | 0.140 |
Why?
| | Crohn Disease | 5 | 2019 | 249 | 0.140 |
Why?
| | Laparotomy | 2 | 2015 | 109 | 0.140 |
Why?
| | Urologic Surgical Procedures | 1 | 2020 | 121 | 0.140 |
Why?
| | Therapeutic Irrigation | 1 | 2018 | 69 | 0.140 |
Why?
| | Surgical Instruments | 1 | 2018 | 51 | 0.140 |
Why?
| | Radiotherapy | 3 | 2003 | 209 | 0.140 |
Why?
| | Chemoradiotherapy, Adjuvant | 2 | 2023 | 44 | 0.130 |
Why?
| | Medicine | 1 | 2019 | 126 | 0.130 |
Why?
| | Gynecology | 1 | 2020 | 184 | 0.130 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 203 | 0.120 |
Why?
| | Botulinum Toxins | 1 | 1997 | 49 | 0.120 |
Why?
| | Propensity Score | 1 | 2019 | 370 | 0.120 |
Why?
| | Internship and Residency | 1 | 2007 | 1269 | 0.120 |
Why?
| | Hirschsprung Disease | 1 | 1997 | 93 | 0.120 |
Why?
| | Surgeons | 1 | 2019 | 337 | 0.110 |
Why?
| | Anastomotic Leak | 1 | 2014 | 45 | 0.100 |
Why?
| | Antimetabolites, Antineoplastic | 4 | 2002 | 108 | 0.100 |
Why?
| | Quality of Life | 4 | 2020 | 3187 | 0.100 |
Why?
| | Rectovaginal Fistula | 1 | 1993 | 11 | 0.100 |
Why?
| | Radiopharmaceuticals | 3 | 2006 | 210 | 0.100 |
Why?
| | Fluorodeoxyglucose F18 | 3 | 2006 | 165 | 0.100 |
Why?
| | Survival Analysis | 8 | 2016 | 1372 | 0.100 |
Why?
| | Colostomy | 2 | 2012 | 28 | 0.100 |
Why?
| | Postoperative Care | 2 | 2013 | 292 | 0.090 |
Why?
| | Bacteria | 1 | 2018 | 766 | 0.090 |
Why?
| | Pilot Projects | 1 | 2018 | 1878 | 0.090 |
Why?
| | Defecation | 1 | 1992 | 18 | 0.090 |
Why?
| | Bioprosthesis | 1 | 2012 | 39 | 0.090 |
Why?
| | Surgical Flaps | 1 | 1993 | 140 | 0.090 |
Why?
| | Anastomosis, Surgical | 4 | 2013 | 161 | 0.090 |
Why?
| | Severity of Illness Index | 5 | 2013 | 2910 | 0.090 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 54 | 0.080 |
Why?
| | Diverticulitis, Colonic | 1 | 2011 | 11 | 0.080 |
Why?
| | Lymphatic Metastasis | 2 | 2010 | 335 | 0.080 |
Why?
| | Chemotherapy, Adjuvant | 5 | 2023 | 429 | 0.080 |
Why?
| | Radiotherapy, High-Energy | 2 | 2001 | 17 | 0.080 |
Why?
| | Lymph Nodes | 2 | 2011 | 511 | 0.080 |
Why?
| | Rosaniline Dyes | 1 | 2010 | 15 | 0.080 |
Why?
| | Salvage Therapy | 2 | 2009 | 163 | 0.080 |
Why?
| | Anus Diseases | 2 | 2004 | 8 | 0.080 |
Why?
| | Coloring Agents | 1 | 2010 | 88 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 236 | 0.080 |
Why?
| | Time Factors | 9 | 2015 | 7079 | 0.070 |
Why?
| | Urodynamics | 2 | 2020 | 44 | 0.070 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2010 | 117 | 0.070 |
Why?
| | Tomography, Emission-Computed | 2 | 2000 | 71 | 0.070 |
Why?
| | Chi-Square Distribution | 4 | 2011 | 511 | 0.070 |
Why?
| | Survival Rate | 6 | 2011 | 2078 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 1996 | 0.070 |
Why?
| | Chemoradiotherapy | 2 | 2023 | 238 | 0.070 |
Why?
| | Adenoma | 1 | 2010 | 209 | 0.070 |
Why?
| | Proportional Hazards Models | 5 | 2008 | 1318 | 0.070 |
Why?
| | Colonoscopy | 1 | 2010 | 254 | 0.070 |
Why?
| | Intestines | 1 | 2010 | 351 | 0.060 |
Why?
| | Vaginal Fistula | 2 | 2013 | 3 | 0.060 |
Why?
| | Prosthesis Implantation | 2 | 2012 | 155 | 0.060 |
Why?
| | Ultrasonography | 4 | 2005 | 788 | 0.060 |
Why?
| | Length of Stay | 4 | 2015 | 1342 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 4 | 2011 | 2766 | 0.060 |
Why?
| | Specialty Boards | 1 | 2007 | 41 | 0.060 |
Why?
| | Research Support as Topic | 1 | 2007 | 81 | 0.060 |
Why?
| | Recurrence | 5 | 2012 | 1125 | 0.060 |
Why?
| | Anesthesia, Local | 2 | 2003 | 27 | 0.060 |
Why?
| | United States | 6 | 2020 | 16041 | 0.060 |
Why?
| | Analysis of Variance | 5 | 2011 | 1293 | 0.060 |
Why?
| | Drug Administration Schedule | 3 | 2014 | 782 | 0.060 |
Why?
| | Age Factors | 5 | 2013 | 3321 | 0.060 |
Why?
| | Ileostomy | 3 | 2011 | 25 | 0.060 |
Why?
| | Ileitis | 1 | 2006 | 33 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2022 | 530 | 0.060 |
Why?
| | Liver Neoplasms | 2 | 2010 | 774 | 0.050 |
Why?
| | Bowen's Disease | 1 | 2004 | 1 | 0.050 |
Why?
| | Mentors | 1 | 2007 | 215 | 0.050 |
Why?
| | HIV Seropositivity | 3 | 2009 | 117 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2006 | 342 | 0.050 |
Why?
| | Missouri | 3 | 2009 | 66 | 0.050 |
Why?
| | Neoplasm, Residual | 2 | 2015 | 143 | 0.050 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2004 | 20 | 0.050 |
Why?
| | Tissue Adhesives | 1 | 2004 | 21 | 0.050 |
Why?
| | Antineoplastic Agents | 2 | 2013 | 2218 | 0.050 |
Why?
| | Morbidity | 2 | 2022 | 317 | 0.050 |
Why?
| | Amifostine | 1 | 2002 | 1 | 0.050 |
Why?
| | Radiation-Protective Agents | 1 | 2002 | 16 | 0.050 |
Why?
| | Anesthetics, Combined | 1 | 2002 | 7 | 0.050 |
Why?
| | Cytoprotection | 1 | 2002 | 55 | 0.050 |
Why?
| | Anesthesia, Intravenous | 1 | 2002 | 23 | 0.050 |
Why?
| | Colitis | 1 | 2006 | 280 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2023 | 87 | 0.050 |
Why?
| | Predictive Value of Tests | 4 | 2004 | 2097 | 0.050 |
Why?
| | Hemorrhoids | 1 | 2002 | 2 | 0.050 |
Why?
| | Surgical Staplers | 1 | 2002 | 5 | 0.050 |
Why?
| | Surgical Stapling | 1 | 2002 | 14 | 0.040 |
Why?
| | Carcinoembryonic Antigen | 1 | 2022 | 40 | 0.040 |
Why?
| | Abdomen | 2 | 2005 | 140 | 0.040 |
Why?
| | Pelvis | 3 | 2011 | 129 | 0.040 |
Why?
| | Intestinal Perforation | 2 | 2012 | 46 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2002 | 137 | 0.040 |
Why?
| | Specialties, Surgical | 1 | 2002 | 83 | 0.040 |
Why?
| | Patient Readmission | 3 | 2013 | 771 | 0.040 |
Why?
| | Pelvic Neoplasms | 1 | 2000 | 24 | 0.040 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2001 | 150 | 0.040 |
Why?
| | Hospitals, University | 2 | 2009 | 176 | 0.040 |
Why?
| | Obesity | 1 | 2013 | 3123 | 0.040 |
Why?
| | Catheter Ablation | 1 | 2003 | 355 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2000 | 76 | 0.040 |
Why?
| | Databases, Factual | 2 | 2019 | 1481 | 0.040 |
Why?
| | Soft Tissue Neoplasms | 1 | 2000 | 133 | 0.040 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2020 | 74 | 0.040 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2020 | 62 | 0.040 |
Why?
| | Uterine Prolapse | 1 | 2018 | 14 | 0.030 |
Why?
| | Forecasting | 2 | 2013 | 386 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2003 | 698 | 0.030 |
Why?
| | Leucovorin | 2 | 2014 | 98 | 0.030 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 1998 | 8 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2010 | 423 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 1998 | 51 | 0.030 |
Why?
| | Sensitivity and Specificity | 4 | 2010 | 1992 | 0.030 |
Why?
| | Patient Selection | 2 | 1999 | 720 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 465 | 0.030 |
Why?
| | Abdominal Abscess | 1 | 1997 | 28 | 0.030 |
Why?
| | Cellulitis | 1 | 1997 | 55 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2001 | 578 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2004 | 805 | 0.030 |
Why?
| | Genetic Markers | 1 | 1998 | 337 | 0.030 |
Why?
| | Intestine, Small | 2 | 2012 | 160 | 0.030 |
Why?
| | Ploidies | 1 | 1996 | 21 | 0.030 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1996 | 48 | 0.030 |
Why?
| | Ileum | 1 | 1997 | 112 | 0.030 |
Why?
| | Endoscopy | 1 | 1999 | 316 | 0.030 |
Why?
| | S Phase | 1 | 1996 | 77 | 0.030 |
Why?
| | Treatment Failure | 3 | 2007 | 358 | 0.030 |
Why?
| | Pressure | 1 | 1996 | 221 | 0.030 |
Why?
| | Contraindications | 2 | 2010 | 88 | 0.030 |
Why?
| | Intraoperative Complications | 3 | 2003 | 154 | 0.030 |
Why?
| | Sensory Thresholds | 1 | 1994 | 31 | 0.030 |
Why?
| | Reflex | 1 | 1994 | 69 | 0.030 |
Why?
| | Organoplatinum Compounds | 1 | 2014 | 65 | 0.030 |
Why?
| | Organ Sparing Treatments | 1 | 2014 | 37 | 0.030 |
Why?
| | Colorectal Neoplasms | 2 | 2003 | 870 | 0.030 |
Why?
| | Medical Illustration | 1 | 1993 | 10 | 0.030 |
Why?
| | Pouchitis | 1 | 2013 | 8 | 0.030 |
Why?
| | Urinary Bladder Fistula | 1 | 2013 | 11 | 0.020 |
Why?
| | Prognosis | 5 | 2004 | 4331 | 0.020 |
Why?
| | Neoplasm Invasiveness | 2 | 2008 | 503 | 0.020 |
Why?
| | Cutaneous Fistula | 1 | 2013 | 17 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2016 | 3633 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2013 | 238 | 0.020 |
Why?
| | Actinomycosis | 1 | 1992 | 5 | 0.020 |
Why?
| | Palliative Care | 3 | 2012 | 1032 | 0.020 |
Why?
| | Remission Induction | 2 | 2004 | 308 | 0.020 |
Why?
| | Infusions, Intravenous | 2 | 2003 | 429 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2013 | 244 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1325 | 0.020 |
Why?
| | Abscess | 1 | 2011 | 77 | 0.020 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2010 | 38 | 0.020 |
Why?
| | Incidence | 2 | 2008 | 2910 | 0.020 |
Why?
| | Pyridines | 1 | 2014 | 606 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 1996 | 1334 | 0.020 |
Why?
| | Mitomycin | 1 | 2009 | 31 | 0.020 |
Why?
| | Lymph Node Excision | 1 | 2010 | 173 | 0.020 |
Why?
| | Risk Factors | 3 | 2013 | 10840 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 959 | 0.020 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2009 | 57 | 0.020 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2009 | 100 | 0.020 |
Why?
| | Chronic Disease | 1 | 1994 | 1824 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1033 | 0.020 |
Why?
| | Sex Factors | 2 | 2005 | 2101 | 0.020 |
Why?
| | Hepatectomy | 1 | 2010 | 254 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2010 | 1531 | 0.020 |
Why?
| | Inguinal Canal | 1 | 2006 | 10 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1709 | 0.010 |
Why?
| | Proctoscopy | 1 | 2005 | 5 | 0.010 |
Why?
| | Pain Measurement | 1 | 2008 | 567 | 0.010 |
Why?
| | Body Mass Index | 1 | 2013 | 2446 | 0.010 |
Why?
| | Adolescent | 3 | 2010 | 22451 | 0.010 |
Why?
| | Blood Loss, Surgical | 1 | 2005 | 116 | 0.010 |
Why?
| | Research Design | 1 | 2010 | 1139 | 0.010 |
Why?
| | Washington | 1 | 2003 | 157 | 0.010 |
Why?
| | Cohort Studies | 2 | 2005 | 6045 | 0.010 |
Why?
| | Anesthesia Recovery Period | 1 | 2002 | 28 | 0.010 |
Why?
| | Carcinoma | 1 | 2004 | 225 | 0.010 |
Why?
| | Sigmoid Neoplasms | 1 | 2002 | 5 | 0.010 |
Why?
| | Young Adult | 2 | 2010 | 14240 | 0.010 |
Why?
| | Texas | 1 | 2003 | 279 | 0.010 |
Why?
| | Midazolam | 1 | 2002 | 69 | 0.010 |
Why?
| | Hernia, Ventral | 1 | 2002 | 20 | 0.010 |
Why?
| | Urinary Retention | 1 | 2002 | 23 | 0.010 |
Why?
| | Blood Transfusion | 1 | 2005 | 393 | 0.010 |
Why?
| | Precipitating Factors | 1 | 2001 | 4 | 0.010 |
Why?
| | Child, Preschool | 1 | 1997 | 11888 | 0.010 |
Why?
| | Rome | 1 | 2001 | 1 | 0.010 |
Why?
| | Propofol | 1 | 2002 | 86 | 0.010 |
Why?
| | Proctitis | 1 | 2001 | 6 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2002 | 166 | 0.010 |
Why?
| | Posture | 1 | 2002 | 180 | 0.010 |
Why?
| | Wound Healing | 1 | 2004 | 348 | 0.010 |
Why?
| | Intraoperative Care | 1 | 2001 | 63 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1073 | 0.010 |
Why?
| | Academic Medical Centers | 1 | 2003 | 560 | 0.010 |
Why?
| | Outpatients | 1 | 2003 | 437 | 0.010 |
Why?
| | Life Tables | 1 | 1998 | 21 | 0.010 |
Why?
| | Recovery of Function | 1 | 2002 | 721 | 0.010 |
Why?
| | Antidotes | 1 | 1999 | 145 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 1998 | 159 | 0.010 |
Why?
| | Vagina | 1 | 1999 | 202 | 0.010 |
Why?
| | HIV Infections | 1 | 1992 | 3210 | 0.010 |
Why?
| | Radiation Tolerance | 1 | 1996 | 101 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 1997 | 693 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1500 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1992 | 3930 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1998 | 1030 | 0.010 |
Why?
| | Reoperation | 1 | 1997 | 633 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2002 | 3005 | 0.010 |
Why?
| | Reaction Time | 1 | 1994 | 434 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 1997 | 352 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3917 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2005 | 6050 | 0.010 |
Why?
| | Actinomyces | 1 | 1992 | 3 | 0.010 |
Why?
| | Feasibility Studies | 1 | 1997 | 1125 | 0.010 |
Why?
| | Melanoma | 1 | 1997 | 764 | 0.000 |
Why?
| | Registries | 1 | 1997 | 2382 | 0.000 |
Why?
|
|
Birnbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|